BioCentury
ARTICLE | Clinical News

Cyclosporine: SANG will begin pivotal bioequivalence trials

May 28, 1996 7:00 AM UTC

SangStat Medical Corp. (SANG), Menlo Park, Calif. Product: Cyclosporine Indication: Immunosuppression in transplant Status: SANG completed GMP manufacturing of its cyclosporine formulation and will be...